| 1 |
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.
|
| 2 |
Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management [J]. BMJ, 2016, 353: i1585.
|
| 3 |
Linder A, Lee T, Fisher J, et al. Short-term organ dysfunction is associated with long-term (10-Yr) mortality of septic shock [J]. Crit Care Med, 2016, 44(8): e728-736.
|
| 4 |
Tapper H, Karlsson A, Mörgelin M, et al. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles [J]. Blood, 2002, 99(5): 1785-1793.
|
| 5 |
Ma H, Liu H, Wu C, et al. Diagnostic value of serum heparin binding protein, blood lactic acid combined with hs-CRP in sepsis and its relationship with prognosis [J]. Evid Based Complement Alternat Med, 2021, 2021: 5023733.
|
| 6 |
Neumann A. Rapid release of sepsis markers heparin-binding protein and calprotectin triggered by anaerobic cocci poses an underestimated threat [J]. Anaerobe, 2022, 75: 102584.
|
| 7 |
Katsaros K, Renieris G, Safarika A, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the emergency department: the prompt multicenter study [J]. Shock, 2022, 57(4): 518-525.
|
| 8 |
Shafer WM, Martin LE, Spitznagel JK. Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate [J]. Infect Immun, 1984, 45(1): 29-35.
|
| 9 |
Flodgaard H, Ostergaard E, Bayne S, et al. Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin. Neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities [J]. Eur J Biochem, 1991, 197(2): 535-547.
|
| 10 |
Pohl J, Pereira HA, Martin NM, et al. Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase [J]. FEBS Lett, 1990, 272(1-2): 200-204.
|
| 11 |
Campanelli D, Detmers PA, Nathan CF, et al. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties [J]. J Clin Invest, 1990, 85(3): 904-915.
|
| 12 |
Neurath H. Evolution of proteolytic enzymes [J]. Science, 1984, 224(4647): 350-357.
|
| 13 |
Brandt K, Lundell K, Brismar K. Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and -4 [J]. Growth Horm IGF Res, 2011, 21(3): 167-173.
|
| 14 |
Schou M, Djurup R, Norris K, et al. Identifying the functional part of heparin-binding protein (HBP) as a monocyte stimulator and the novel role of monocytes as HBP producers [J]. Innate Immun, 2011, 17(1): 60-69.
|
| 15 |
Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils [J]. J Biol Chem, 1996, 271(6): 2935-2940.
|
| 16 |
Wu YL, Yo CH, Hsu WT, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis [J]. Crit Care Med, 2021, 49(1): e80-e90.
|
| 17 |
Skondra D, Noda K, Almulki L, et al. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown [J]. Invest Ophthalmol Vis Sci, 2008, 49(2): 726-731.
|
| 18 |
Bentzer P, Fisher J, Kong HJ, et al. Heparin-binding protein is important for vascular leak in sepsis [J]. Intensive Care Med Exp, 2016, 4(1): 33.
|
| 19 |
Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability [J]. Nat Med, 2001, 7(10): 1123-1127.
|
| 20 |
Raghu H, Lepus CM, Wang Q, et al. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis [J]. Ann Rheum Dis, 2017, 76(5): 914-922.
|
| 21 |
Chang M, Guo F, Zhou Z, et al. HBP induces the expression of monocyte chemoattractant protein-1 via the FAK/PI3K/AKT and p38 MAPK/NF-κB pathways in vascular endothelial cells [J]. Cell Signal, 2018, 43: 85-94.
|
| 22 |
Heinzelmann M, Kim E, Hofmeister A, et al. Heparin binding protein (CAP37) differentially modulates endotoxin-induced cytokine production [J]. Int J Surg Investig, 2001, 2(6): 457-466.
|
| 23 |
Soehnlein O, Weber C, Lindbom L. Neutrophil granule proteins tune monocytic cell function [J]. Trends Immunol, 2009, 30(11): 538-546.
|
| 24 |
Honore PM, De Bels D, Barreto Gutierrez L, et al. Heparin-binding protein in sepsis: player predictor positioning? [J] Ann Intensive Care, 2019, 9(1): 71.
|
| 25 |
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis [J]. N Engl J Med, 2003, 348(2): 138-150.
|
| 26 |
Dou QL, Liu J, Zhang W, et al. Dynamic changes in heparin-binding protein as a prognostic biomarker for 30-day mortality in sepsis patients in the intensive care unit [J]. Sci Rep, 2022, 12(1): 10751.
|
| 27 |
Sanaei Dashti A, Alizadeh S, Karimi A, et al. Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis: A cross-sectional study [J]. Medicine (Baltimore), 2017, 96(35): e7637.
|
| 28 |
Bisaria S, Terrigno V, Hunter K, et al. Association of elevated levels of inflammatory marker high-sensitivity C-reactive protein and hypertension [J]. J Prim Care Community Health, 2020, 11: 2150132720984426
|
| 29 |
中国严重脓毒症/脓毒性休克治疗指南(2014) [J]. 中华内科杂志, 2015, 54(6): 557-581.
|
| 30 |
Halldorsdottir HD, Eriksson J, Persson BP, et al. Heparin-binding protein as a biomarker of post-injury sepsis in trauma patients [J]. Acta Anaesthesiol Scand, 2018, 62(7): 962-973.
|
| 31 |
Zhou Y, Liu Z, Huang J, et al. Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China [J]. BMJ Open, 2019, 9(4): e026527.
|
| 32 |
Linder A, Christensson B, Herwald H, et al. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009 Oct 1; 49(7): 1044-50.
|
| 33 |
Linder A, Åkesson P, Inghammar M, et al. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock [J]. Crit Care, 2012, 16(3): R90.
|
| 34 |
Kahn F, Tverring J, Mellhammar L, et al. Heparin-binding protein as a prognostic biomarker of sepsis and disease severity at the emergency department [J]. Shock, 2019, 52(6): e135-e145.
|
| 35 |
Linder A, Akesson P, Brink M, et al. Heparin-binding protein: a diagnostic marker of acute bacterial meningitis [J]. Crit Care Med, 2011, 39(4): 812-817.
|
| 36 |
Kong Y, Ye Y, Ma J, et al. Accuracy of heparin-binding protein for the diagnosis of nosocomial meningitis and ventriculitis [J]. Crit Care, 2022, 26(1): 56.
|
| 37 |
Kjölvmark C, Påhlman LI, Åkesson P, et al. Heparin-binding protein: a diagnostic biomarker of urinary tract infection in adults [J]. Open Forum Infect Dis, 2014 Apr 23; 1(1): ofu004.
|
| 38 |
Janssen van Doorn K, Spapen H, Geers C, et al. Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment? [J] Acta Anaesthesiol Scand, 2008, 52(9): 1259-1264.
|
| 39 |
Aksoy Y, Yapanoglu T, Aksou H, et al. The effect of dehydroepiandrosterone on renal ischemia-reperfusion-induced oxidative stress in rabbits [J]. Urol Res, 2004, 32(2): 93-96.
|
| 40 |
Fisher J, Linder A, Bentzer P, et al. Is heparin-binding protein inhibition a mechanism of albumin's efficacy in human septic shock? [J]. Crit Care Med, 2018, 46(5): e364-e374.
|
| 41 |
Tverring J, Vaara ST, Fisher J, et al. Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury [J]. Ann Intensive Care, 2017, 7(1): 105.
|
| 42 |
Pajenda S, Figurek A, Wagner L, et al. Heparin-binding protein as a novel biomarker for sepsis-related acute kidney injury [J]. Peer J, 2020, 8: e10122.
|
| 43 |
Fisher J, Russell JA, Bentzer P, et al. Heparin-binding protein (HBP): a causative marker and potential target for heparin treatment of human sepsis-induced acute kidney injury [J]. Shock, 2017, 48(3): 313-320.
|
| 44 |
Xing L, Zhongqian L, Chunmei S, et al. Activation of M1 macrophages in sepsis-induced acute kidney injury in response to heparin-binding protein [J]. PLoS One, 2018, 13(5): e0196423.
|
| 45 |
Guo R, Li Y, Han M, et al. Emodin attenuates acute lung injury in Cecal-ligation and puncture rats [J]. Int Immunopharmacol, 2020, 85: 106626.
|
| 46 |
Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis [J]. Am J Respir Crit Care Med, 2020, 202(3): 361-370.
|
| 47 |
Huang X, Hu H, Sun T, et al. Plasma endothelial glycocalyx components as a potential biomarker for predicting the development of disseminated intravascular coagulation in patients with sepsis [J]. J Intensive Care Med, 2021, 36(11): 1286-1295.
|
| 48 |
Bellingan GJ. The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS [J]. Thorax, 2002, 57(6): 540-546.
|
| 49 |
Tydén J, Herwald H, Sjöberg F, et al. Increased plasma levels of heparin-binding protein on admission to intensive care are associated with respiratory and circulatory failure [J]. PLoS One, 2016, 11(3): e0152035.
|
| 50 |
Lin Q, Shen J, Shen L, et al. Increased plasma levels of heparin-binding protein in patients with acute respiratory distress syndrome [J]. Crit Care, 2013, 17(4): R155.
|
| 51 |
Chen D, Xu W, Lei Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: a case report [J]. Int J Infect Dis, 2020, 93: 297-299.
|
| 52 |
Montali F, Palmieri G, Casali L, et al. Rapidly fatal outcome of Covid-19 after successful emergency surgery during pandemic outbreak in Northern Italy [J]. Int J Surg Case Rep, 2020, 73: 9-12.
|
| 53 |
Bos JM, Hebl VB, Oberg AL, et al. Marked Up-Regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2-mediated COVID-19 [J]. Mayo Clin Proc, 2020, 95(7): 1354-1368.
|
| 54 |
Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges [J]. Lancet Gastroenterol Hepatol, 2020, 5(5): 428-430.
|
| 55 |
Agrati C, Sacchi A, Bordoni V, et al. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) [J]. Cell Death Differ, 2020, 27(11): 3196-3207.
|
| 56 |
Saridaki M, Metallidis S, Grigoropoulou S, et al. Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19) [J]. Eur J Clin Microbiol Infect Dis, 2021, 40(7): 1405-1412.
|
| 57 |
Mellhammar L, Thelaus L, Elén S, et al. Heparin binding protein in severe COVID-19-A prospective observational cohort study [J]. PLoS One, 2021, 6, 16(4): e0249570.
|